Pay in 4 interest-free payments of $6.89 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
These results were sustained for 12 weeks after treatment
The April 2026 TGA alert regarding unapproved GLP-1 receptor agonists (including Retatrutide) reinforced the distinction between therapeutic use, which remains unapproved, and research-grade supply for laboratory purposes, which is legally distinct under Australian law
References Author View all posts Dr
However, their popularity has rapidly spread to individuals without obesity or metabolic disorders, who use them off-label to achieve or maintain slimness
Most patients find weekly injections fit easily into their routine, often choosing a specific day that will cause the least disruption to their routine maintain consistency
Furthermore, rising launch of novel formulations such as long-acting therapies with dosing convenience can drive the market growth
